Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Prostate Cancer
Interventions: Stravix lyopreserved placental tissue (LPT), Radical prostatectomy; Drug · Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 65 Years · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Salivary Gland Tumor
Interventions: MRI; Diagnostic Test
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy Aging
Interventions: Tai Chi Exercise, Tai Chi; Behavioral
Lead sponsor: Harvard University Faculty of Medicine; Other
Eligibility: 50 Years to 79 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: Hypoparathyroidism
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy
Interventions: Dabigatran etexilate (DE), Rosuvastatin, PF-07081532; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: South Miami, Florida

Conditions: Erectile Dysfunction
Interventions: Erchonia HLS; Device
Lead sponsor: Erchonia Corporation; Industry
Eligibility: 40 Years to 80 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Obstetric Labour, Premature, Premature Ejaculation
Interventions: GSK221149; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Phantom Limb Pain
Interventions: Psilocybin, Placebo Niacin; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2031
U.S. locations: 1
States / cities: San Diego, California

Conditions: Gynecologic Cancer
Interventions: Surveys; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Total Hip Arthroplasty (THA), Impaction, Physiological Strain
Interventions: Automated Impaction (HAMMR), Manual Malleting; Device
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections, Cachexia
Interventions: testosterone; Drug
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2001
U.S. locations: 3
States / cities: Los Angeles, California • Torrance, California • St Louis, Missouri

Conditions: Erectile Dysfunction, Prostate Cancer
Interventions: Tacrolimus, Placebo; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: Up to 65 Years · Male only
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 6
States / cities: Ann Arbor, Michigan • New York, New York • Cleveland, Ohio + 2 more

Conditions: Pelvic Organ Prolapse, Urinary Incontinence,Stress, Urinary Incontinence, Urge, Bowel Dysfunction, Sexual Dysfunction
Interventions: Laparoscopic Burch Colposuspension; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Chicago, Illinois • Maywood, Illinois

Conditions: Prostate Cancer, Sexual Dysfunction and Infertility, Sexuality
Interventions: communication intervention, counseling intervention, nutrition intervention, questionnaire administration; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 483 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 6
States / cities: New Brunswick, New Jersey • Newark, New Jersey • Whippany, New Jersey + 2 more

Conditions: Brain Edema, Stroke, Acute
Interventions: BIIB093, Placebo; Drug
Lead sponsor: Remedy Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 535 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 74
States / cities: Phoenix, Arizona • Tucson, Arizona • Palo Alto, California + 59 more

Conditions: Vascular Diseases
Interventions: Phenylephrine, Dexmedetomidine, Clevidipine, tetanic stimulus, Increased venous pressure, Calcium Chloride; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction, Cardiac Failure, Heart Diseases
Interventions: Beta blocker; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 65 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Leukemia, Long-term Effects Secondary to Cancer Therapy in Adults, Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma, Sexual Dysfunction and Infertility, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: laboratory biomarker analysis, fertility assessment and management, management of therapy complications, ultrasound imaging; Other · Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 14 Years to 35 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Artery Disease
Interventions: physiological assessment with Volcano Verrata pressure wire (iFR); Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 90 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Contact Lens-induced Corneal Fluorescein Staining
Interventions: ReNu Multiplus multipurpose disinfecting solution, Control; Device
Lead sponsor: Southern California College of Optometry at Marshall B. Ketchum University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Fullerton, California

Conditions: Impotence, Prostate Cancer
Interventions: GPI 1485; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 40 Years to 69 Years · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 25
States / cities: Phoenix, Arizona • La Mesa, California • Stanford, California + 19 more

Conditions: Stroke, Acute
Interventions: Not listed
Lead sponsor: University of Indianapolis; Other
Eligibility: 21 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cataract
Interventions: Cataract surgery at high IOP, Cataract surgery at low IOP; Procedure
Lead sponsor: Wolfe Eye Clinic; Other
Eligibility: 55 Years to 95 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Hiawatha, Iowa

Conditions: Eosinophilic Esophagitis
Interventions: CC-93538; Drug
Lead sponsor: Celgene; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 367 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 81
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 72 more

Search by objective public record fields.

Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care

Physiologic MR Imaging of Salivary Gland Tumors

Tai Chi, Physiologic Complexity, and Healthy Aging

Physiologic Regulation of FGF-23

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

Effect of Erchonia Laser on Erectile Dysfunction

A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

Psilocybin-assisted Therapy for Phantom Limb Pain

Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients

Automated V Manual Impactor Study

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence

Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study

A Preliminary Study for INFORMED

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

Diastolic Hyperemia Free Index for Assessment of Moderate Coronary Stenoses

Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear

Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

Physiological Complexity of Gait Over the First Six Months Post Stroke

Physiologic Phacofluidics: Ghost Protocol

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis